| [1] |
Shi W, Indelicato DJ, Morris CG, et al. Long-term treatment outcomes for patients with synovial sarcoma: A 40-year experience at the University of Florida[J]. Am J Clin Oncol, 2013, 36 (1): 83-8.
|
| [2] |
Haldar M, Randall RL, Capecchi MR. Synovial sarcoma: from genetics to genetic-based animal modeling[J]. Clin Orthop Relat Res, 2008, 466(9): 2156-67.
|
| [3] |
Antonescu CR, Kawai A, Leung DH, et al. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma[J]. Diagn Mol Pathol, 2000, 9(1): 1-8.
|
| [4] |
Brett D, Whitehouse S, Antonson P, et al. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localized in nuclear bodies[J]. Hum Mol Genet, 1997, 6(9): 1559-64.
|
| [5] |
Yoneda Y, Ito S, Kunisada T, et al. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein[J]. PLoS One, 2013, 8( 10): e77564.
|
| [6] |
Cai W, Sun Y, Wang W, et al. The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma[J]. Pathol Oncol Res, 2011, 17(2): 357-67.
|
| [7] |
Carmody Soni EE, Schlottman S, Erkizan HV, et al. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma[J]. Clin Orthop Relat Res, 2014, 472(3): 874-82.
|
| [8] |
Barham W, Frump AL, Sherrill TP, et al. Targeting the wnt pathway in synovial sarcoma models[J]. Cancer Discov, 2013, 3( 11): 1286-301.
|
| [9] |
Sinnberg T, Menzel M, Kaesler S, et al. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis[J]. Cancer Res, 2010, 70(17): 69 99-7009.
|
| [10] |
Elyada E, Pribluda A, Goldstein RE, et al. CKIα ablation highlights a critical role for p53 in invasiveness control[J]. Nature, 20 11, 470(7334): 409-13.
|
| [11] |
Thorne CA, Hanson AJ, Schneider J, et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1& alpha;[J]. Nat Chem Biol, 2010, 6(11): 829-36.
|
| [12] |
Barco R, Garcia CB, Eid JE. The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1[J]. PLoS One, 2009, 4(4): e5060.
|
| [13] |
Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation[J]. Nature, 2001, 411(6841): 10 17-21.
|
| [14] |
Recchia AG, Musti AM, Lanzino M, et al. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells[J]. Int J Biochem Cell Biol, 2009, 41(3): 603-14.
|
| [15] |
Bockstaele L, Coulonval K, Kooken H, et al. Regulation of CDK4[J]. Cell Div, 2006, 1: 25.
|
| [16] |
Lobenhofer EK, Huper G, Iglehart JD, et al. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis[J]. Cell Growth Differ, 2000, 11(2): 99-110.
|
| [17] |
Squires MS, Nixon PM, Cook SJ. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/ 2 but not ERK5/BMK1[J]. Biochem J, 2002, 366(Pt 2): 673-80.
|
| [18] |
Motti ML, De Marco C, Califano D, et al. Loss of p27 expression through RAS->BRAF->MAP kinase-dependent pathway in human thyroid carcinomas[J]. Cell Cycle, 2007, 6(22): 2817-25.
|
| [19] |
Amary MF, Berisha F, Bernardi Fdel C, et al. Detection of SS18- SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma[J]. Mod Pathol, 2007, 20(4): 482-96.
|
| [20] |
Kawaguchi S, Tsukahara T, Ida K, et al. SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group[J]. Cancer Sci, 20 12, 103(9): 1625-30.
|
| [21] |
Heldin CH, Vanlandewijck M, Moustakas A. Regulation of EMT by TGFbeta in cancer[J]. FEBS Lett, 2012, 586(14): 1959-70.
|
| [22] |
Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes[J]. Cell Cycle, 2010, 9( 12): 2363-74.
|
| [23] |
Qi Y, Wang CC, He YL, et al. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas[J]. Int J Clin Exp Pathol, 2013, 6(12): 2787-99.
|
| [24] |
Hajra KM, Chen DY, Fearon ER. The SLUG zincfinger protein represses E-cadherin in breast cancer[J]. Cancer Res, 2002, 62(6): 16 13-8.
|
| [25] |
Saito T, Nagai M, Ladanyi M. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma[J]. Cancer Res, 2006, 66(14): 6919-27.
|
| [26] |
Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell, 2009, 139(5): 87 1-90.
|
| [27] |
Su b r ama n i am MM, Na v a r r o S, Ll omb a r t -Bo s c h A. Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transitionrelated proteins in synovial sarcomas[J]. Arch Pathol Lab Med, 20 11, 135(8): 1001-9.
|
| [28] |
Shin NR, Jeong EH, Choi CI, et al. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer[J]. BMC Cancer, 2012, 12: 521.
|
| [29] |
Ahmad A, Sarkar SH, Bitar B, et al. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells[J]. Mol Cancer Ther, 2012, 11 (10): 2193-201.
|
| [30] |
Javelaud D, Pierrat MJ, Mauviel A. Crosstalk between TGF-β and hedgehog signaling in cancer[J]. FEBS Lett, 2012, 586(14): 20 16-25.
|
| [31] |
Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions[J]. J Clin Invest, 2009, 119(6): 1429-37.
|
| [32] |
Lee KW, Lee NK, Ham S, et al. Twist1 is essential in maintaining mesenchymal state and tumor-initiating properties in synovial sarcoma[J]. Cancer Lett, 2014, 343(1): 62-73.
|
下载:
